In December of 2006, Genespectrum Inc was acquired by NABsys of Providence, RI. GeneSpectrum is an early stage biotechnology company founded to develop and commercialize a proprietary approach for DNA sequence determination. The cost and time of DNA sequencing with our technology is projected to fall 100-fold. GeneSpectrum products will enable significant time and cost savings during the analysis of biological samples for applications in pharmacogenomics, diagnostics, and large scale sequencing efforts